Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/Phase 2 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema

NCT00205907 is registered in ClinicalTrials.gov with Aeris Therapeutics as lead sponsor.

NCT NCT00205907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00205907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/Phase 2 Study of the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System in Patients With Advanced Emphysema
Lead sponsor
Aeris Therapeutics
Phase
Phase 1/2
Overall status
Terminated
Start date
January 31, 2005
Completion date
April 30, 2007
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary emphysema